Although mutations observed in genes that cause the inactivation of Wnt-CTNNB1 signaling has been identified in other disorders but not in cancer.64 Depending on the stage and type of cancer, Wnt-CTNNB1 signaling pathway can either promote or inhibit the tumor initiation, growth, metastasis and drug resistance. This evidence concerns the gene CTNNB1 and neoplasm.